Compare REG & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | REG | WST |
|---|---|---|
| Founded | 1963 | 1923 |
| Country | United States | United States |
| Employees | 507 | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.2B | 17.9B |
| IPO Year | N/A | 2004 |
| Metric | REG | WST |
|---|---|---|
| Price | $76.57 | $238.80 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 7 |
| Target Price | $78.54 | ★ $319.43 |
| AVG Volume (30 Days) | ★ 893.5K | 720.7K |
| Earning Date | 04-28-2026 | 04-23-2026 |
| Dividend Yield | ★ 3.95% | 0.37% |
| EPS Growth | N/A | ★ 1.49 |
| EPS | N/A | ★ 6.79 |
| Revenue | N/A | ★ $2,886,900,000.00 |
| Revenue This Year | $1.61 | $6.73 |
| Revenue Next Year | $4.22 | $6.07 |
| P/E Ratio | ★ $26.85 | $35.17 |
| Revenue Growth | N/A | ★ 1.95 |
| 52 Week Low | $63.44 | $187.43 |
| 52 Week High | $79.90 | $322.34 |
| Indicator | REG | WST |
|---|---|---|
| Relative Strength Index (RSI) | 48.42 | 45.29 |
| Support Level | $69.66 | $230.42 |
| Resistance Level | $77.39 | $251.73 |
| Average True Range (ATR) | 1.22 | 6.73 |
| MACD | -0.46 | -0.38 |
| Stochastic Oscillator | 5.14 | 33.95 |
Regency Centers is one of the largest shopping center-focused retail REITs. The company's portfolio includes an interest in 481 properties, which includes over 58 million square feet of retail space following the completion of the Urstadt Biddle acquisition in August 2023. The portfolio is geographically diversified with 22 regional offices and no single market representing more than 12% of total company net operating income. Regency's retail portfolio is primarily composed of grocery-anchored centers, with 80% of properties featuring a grocery anchor and grocery stores representing 20% of annual base rent.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.